|
AU2005271831A1
|
|
Tetrapeptide analogs
|
|
CN101094833A
|
|
Tetrapeptide analogs
|
|
CA2475653A1
|
|
(substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases
|
|
AU2002245649A1
|
|
Methods, compositions and kits for preserving antigenicity
|
|
AU4150802A
|
|
Membrane derived caspase-3, compositions comprising the same and methods of use therefor
|
|
US2002128306A1
|
|
Treatment of infectious disease using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitors
|
|
US2002123522A1
|
|
Inhibition of inflammation using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitors
|
|
AU5590701A
|
|
Inhibition of apoptosis using interleukin-1beta converting enzyme (ICE)/CED-3 family inhibitors
|
|
US7157430B2
|
|
(Substituted)acyl dipeptidyl inhibitors of the ICE/CED-3 family of cysteine proteases
|
|
US6790989B2
|
|
Inhibitors of the ICE/ced-3 family of cysteine proteases
|
|
US6525024B1
|
|
Inhibitors of the ICE/ced-3 family of cysteine proteases
|
|
EP1276717A2
|
|
Inhibitors of the ice/ced-3 family of cysteine proteases
|
|
US7053056B2
|
|
C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases
|
|
ZA200100023B
|
|
C-terminal modified oxamyl dipeptides as inhibitors of the ICE/CED-3 family of cysteine proteases.
|
|
US6544951B2
|
|
C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases
|
|
US6515173B1
|
|
Inhibitors of the ICE/ced-3 family of cysteine proteases
|
|
CA2347792A1
|
|
(substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases
|
|
US6184244B1
|
|
C-terminal modified (N-substituted)-2-indolyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases
|
|
US6391575B1
|
|
Methods for detecting membrane derived caspase activity and modulators thereof
|
|
US6197750B1
|
|
C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases
|
